Tag: (ASX:CSL)
Paul McKenzie to take reins as CSL’s new CEO, managing director
Global biotechnology giant CSL Limited has named Paul McKenzie as its chief executive officer and managing director, effective 6 March 2023.
CSL makes record 45% profit leap, takes on vaccine manufacturing
As demand for vaccines ramps up, the blood products giant has taken on the enormous task of manufacturing COVID-19 jabs – and so far,...
Featured Article
Balancing profit and sustainability in supply chains
Priorities in the supply chain are expanding, moving away from cost as the main driver behind purchasing decisions. Now, sustainability and ethical sourcing are grabbing a portion of the spotlight.
